NCT03109080: Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

NCT03109080
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: Inflammatory breast cancer
Recruitment Status: Recruiting
Ph+ase 1
Drug Category: Misc Inhibitor, Radiation Therapy

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Senior)
Location of Metastases: 
Additional Notes: Must be affiliated with the French Social Security System
Exclusions: 
https://ClinicalTrials.gov/show/NCT03109080

Comments are closed.

Up ↑